All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2004-002015-86 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Scalp Psoriasis. | 2005-09-08 | due-trials |
| Reported results | 2004-002152-33 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle and Calcipotriol in the Gel Vehicle in Scalp Psoriasis. A phase III study comparing a gel con... | 2015-07-12 | due-trials |
| Reported results | 2004-002687-14 | Fucidin® Cream in the Treatment of Impetigo A phase IV study comparing clinical and bacteriological efficacy of Fucidin® cream with Fucidin® cream vehicle in the treatment of impetigo in paediatric pa... | 2005-03-11 | due-trials |
| Reported results | 2004-002861-19 | Long-term treatment of Scalp Psoriasis with Calciptriol plus Betamethasone dipropionate gel. A phase III safety study of a new gel containing calcipotriol 50mcg/g plus betamethasone 0.5 mg/g (as dipro... | 2006-09-22 | due-trials |
| Reported results | 2004-004577-28 | Different treatment regimens of calcipotriol cream and combination (calcipotiol/betamethasone dipropionate) ointment in psoriasis vulgaris | 2005-12-13 | due-trials |
| Reported results | 2005-002270-29 | Safety profile of innohep versus subcutaneous unfractionated Heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis | 2008-05-26 | due-trials |
| Reported results | 2005-002864-27 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients with Scalp Psoriasis. A phase III study comparing a gel containing calcipotriol 50 mcg/g plus b... | 2006-05-17 | due-trials |
| Reported results | 2005-003215-78 | Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Psoriasis Vulgaris. | 2006-05-08 | due-trials |
| Reported results | 2006-001472-20 | LEO19123 Cream in the Treatment of Atopic Dermatitis A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment... | 2007-08-24 | due-trials |
| Reported results | 2006-002686-39 | LEO19123 Cream in the Treatment of Hand Eczema A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment of ha... | 2007-07-11 | due-trials |
| Reported results | 2006-002873-35 | Exploratory efficacy and safety, pharmacokinetics and dose-finding study of ATryn® (antithrombin alfa) in patients with disseminated intravascular coagulation associated with severe sepsis | 2009-03-18 | due-trials |
| Reported results | 2007-003365-41 | Calcipotriol Plus Hydrocortisone Ointment Compared with Tacalcitol Ointment in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment conta... | 2009-06-18 | due-trials |
| Reported results | 2007-004782-18 | Calcipotriol Plus Hydrocortisone in Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g ... | 2010-11-11 | due-trials |
| Reported results | 2007-005463-10 | A plaque test comparing three marketed products and two products in development and a vehicle control for the treatment of psoriasis vulgaris | 2008-03-31 | due-trials |
| Reported results | 2007-005501-22 | Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas | 2009-12-08 | due-trials |
| Reported results | 2008-005456-24 | Safety and Efficacy of Calcipotriol plus Betamethasone Dipropionate Gel in Adolescent Patients (Aged 12 to 17 Years) with Scalp Psoriasis | 2012-10-15 | due-trials |
| Reported results | 2008-005487-13 | A plaque test comparing 4 steroids with Daivobet® ointment and a vehicle control for the treatment of psoriasis vulgaris | 2009-03-02 | due-trials |
| Reported results | 2009-010963-18 | A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g (LEO 80190 ointment) with hydrocortisone 10 mg/g ointment, both applied once daily in the treatment o... | 2010-06-08 | due-trials |
| Reported results | 2009-013792-22 | A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pimecr... | 2010-06-30 | due-trials |
| Reported results | 2009-017858-12 | A phase 2a proof of concept study comparing three doses of an oral solution of LEO 22811 with a placebo oral solution for the treatment of psoriasis vulgaris | 2011-07-25 | due-trials |
| Reported results | 2009-018141-20 | A Phase 3 Study of Subcutaneous Innohep 20,000 anti-Xa IU/ml for the Treatment of Venous Thromboembolism (VTE) in Cancer Patients | 2014-06-25 | due-trials |
| Completed, but no date Terminated | 2010-021941-38 | LEO 90110 ointment in the treatment of psoriasis vulgaris | bad-data | |
| Reported results | 2011-005018-13 | Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp | 2014-02-04 | due-trials |
| Reported results Terminated | 2011-006275-20 | A phase II exploratory study evaluating the efficacy of topical cromoglicate solution(20mg/ml) compared to topical solution vehicle in the treatment of mastocytosis | 2013-03-05 | due-trials |
| Reported results | 2012-000253-30 | An exploratory study evaluating the efficacy of cromoglicate cream compared to cream vehicle in the treatment of itch in psoriasis Eine explorative Studie, die die Wirksamkeit einer Cromoglicat-Cre... | 2013-04-11 | due-trials |
| Reported results | 2012-002863-88 | A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen with Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas with Actinic Keratosis on Face/Scalp and Trunk/Extremities Un reg... | 2014-01-22 | due-trials |
| Reported results | 2012-003112-31 | Risk of Squamous Cell Carcinoma on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% | 2019-07-11 | due-trials |
| Reported results | 2013-000410-38 | Topical Aprepitant in Prurigo Patients (iTAPP) An exploratory phase IIa trial with topically applied aprepitant in patients with prurigo Topisches Aprepitant bei Patienten mit Prurigo (iTAPP) Ein... | 2014-07-28 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2013-001538-16 | Effect of Calcipotriol plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 months) with Scalp and Body Psoriasis | 2018-02-13 | bad-data |
| Reported results | 2013-004686-14 | LEO 90100 aerosol foam compared to calcipotriol plus betamethasone dipropionate gel in subjects with psoriasis vulgaris | 2015-03-04 | due-trials |
| Reported results | 2014-000037-23 | Clinical Study Protocol Safety and efficacy of escalating doses of LEO 43204 applied once daily for two consecutive days on full balding scalp in subjects with actinic keratosis Part 1: A phase 1, m... | 2015-03-06 | due-trials |
| Reported results | 2014-003072-24 | Patient insights following use of LEO 90100 aerosol foam and Daivobet® gel in subjects with psoriasis vulgaris | 2015-11-30 | due-trials |
| Reported results | 2014-003218-98 | Efficacy and safety of ingenol mebutate gel 0.015% compared to diclofenac sodium gel 3% in subjects with actinic keratoses on the face or scalp. | 2016-07-13 | due-trials |
| Reported results | 2014-004465-24 | Safety and efficacy of repeat use of Picato® 0.05% in the treatment of anogenital warts | 2015-11-26 | due-trials |
| Reported results | 2014-004759-30 | A psoriasis plaque test trial with LP0113 spray in patients with psoriasis vulgaris | 2016-05-30 | due-trials |
| Reported results | 2015-000839-33 | Safety and Effect of LEO 90100 aerosol foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) with Plaque Psoriasis A phase 2 trial evaluating the safety and effic... | 2018-03-28 | due-trials |
| Reported results | 2015-001798-41 | A psoriasis plaque test trial with LEO 90100 compared to Betesil® in patients with psoriasis vulgaris | 2015-12-07 | due-trials |
| Reported results | 2015-002098-40 | A Phase 2a, Proof of Concept Trial, testing twice daily application of LEO 124249 ointment 30mg/g in the treatment of mild to moderate inverse psoriasis | 2016-09-19 | due-trials |
| Reported results | 2015-002449-71 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exte... | 2017-11-14 | due-trials |
| Reported results | 2015-002450-12 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exte... | 2017-08-10 | due-trials |
| Reported results | 2015-002451-10 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exten... | 2017-09-06 | due-trials |
| Reported results | 2015-002452-27 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exte... | 2017-10-27 | due-trials |
| Reported results | 2015-005279-25 | LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris A phase 2a proof of concept study comparing an oral tablet formulation of LEO 32731 with a corresponding placebo tablet in patients... | 2017-07-06 | due-trials |
| Reported results | 2016-000556-95 | LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris | 2019-07-02 | due-trials |
| Reported results | 2016-003867-21 | A phase 4 trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate to severe plaque psoriasis | 2019-05-02 | due-trials |
| Reported results | 2016-004200-65 | A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... | 2019-10-10 | due-trials |
| Reported results | 2016-004201-13 | A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... | 2019-08-15 | due-trials |
| Reported results Terminated | 2017-000228-85 | Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis treated with ingenol disoxate gel 0.018% or 0.037%, or vehicle A phase 3 trial to compare the incidenc... | 2018-03-12 | due-trials |
| Reported results | 2017-002065-21 | A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroid in subjects with moderate-to-severe atopic ... | 2019-09-26 | due-trials |
| Reported results Terminated | 2017-002720-24 | Efficacy of twice daily application of LEO 124249 ointment 30 mg/g for 12 weeks on eyebrow alopecia areata. Exploratory Phase 2a | 2018-05-16 | due-trials |
| Reported results Terminated | 2017-004508-23 | Capture of LEO 90100 medication usage with digital tracker and evaluation of efficacy in patients with psoriasis | 2018-06-11 | due-trials |
| Ongoing | 2017-004998-13 | Adjustable brodalumab dosage regimen compared with standard brodalumab treatment for 52 weeks in subjects with moderate-to-severe plaque psoriasis and =120 kg body weight Regime di dosaggio di brod... | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2017-005143-33 | A randomised, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate the efficacy, safety, and tolerability of tralokinumab monotherapy in adolescent subjects with moderate-t... | 2021-03-16 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2018-000746-19 | An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clin... | 2024-07-03 | bad-data |
| Reported results | 2018-000747-76 | A randomised, double-blind, placebo-controlled, parallel-group, multi-centre, phase 3 trial investigating the efficacy, safety, and tolerability of tralokinumab administered in combination with topica... | 2020-09-28 | due-trials |
| Reported results | 2018-000900-40 | A phase 2b, double-blind, randomised, 5-arm, vehicle-controlled, dose-ranging trial to evaluate the efficacy and safety of twice daily topical application of delgocitinib cream 1, 3, 8, and 20 mg/g fo... | 2020-04-20 | due-trials |
| Reported results Terminated | 2018-003615-22 | Efficacy and safety of twice-daily application of delgocitinib cream 20 mg/g for 6 weeks in subjects with active discoid lupus erythematosus. A phase 2a exploratory, randomised, double-blind, vehicle-... | 2020-05-07 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2019-001868-30 | A phase 3, randomised, double-blind, multi-centre trial to evaluate the efficacy, safety, and tolerability of brodalumab treatment compared to placebo (blinded) and ustekinumab (open-label) in adolesc... | 2023-06-27 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2019-004099-20 | Efficacy and safety comparison of brodalumab versus guselkumab in adult subjects with moderate-to-severe plaque psoriasis and inadequate response to ustekinumab. | 2022-12-01 | bad-data |
| Reported results | 2020-002960-30 | A phase 3 clinical trial to confirm efficacy and evaluate safety of twice-daily delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adult subjects with moderate to... | 2022-10-31 | due-trials |
| Reported results | 2020-002961-32 | A phase 3 clinical trial to confirm efficacy and evaluate safety of twice-daily delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adult subjects with moderate to... | 2023-01-06 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2020-002962-15 | A phase 3 extension trial of DELTA 1 and DELTA 2 to evaluate the long-term safety of a twice-daily treatment with delgocitinib cream 20 mg/g as needed for up to 36 weeks in adult subjects with chronic... | 2023-09-18 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2020-003929-27 | Assessing target lesion score via daily photograph capture in subjects with psoriasis vulgaris on the body treated once daily with topical LEO 90100 (calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g ... | 2023-02-02 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2020-004561-39 | A phase 2 trial to evaluate the efficacy and safety of orally administered LEO 152020 tablets compared with placebo tablets for up to 16 weeks of treatment in adults with moderate to severe atopic der... | 2023-07-26 | bad-data |
| Reported results | 2020-004961-38 | Phase 2a trial to assess the efficacy and safety of LEO 152020 in adult patients with cholinergic urticaria Phase 2a Studie zur Beurteilung der Wirksamkeit und Sicherheit von LEO 152020 bei erwachs... | 2022-07-11 | due-trials |
| Reported results | 2020-005541-16 | A phase 2a, randomised, double-blind, placebo-controlled, multi-site, proof of concept trial to evaluate the efficacy and safety of LEO 138559 in adult subjects with moderate to severe atopic dermatit... | 2022-09-26 | due-trials |
| Trial is outside EEC, and reported results | 2021-000404-37 | A phase 1 open-label, multi-centre, single-arm trial to evaluate the safety and pharmacokinetics (including MUsT) of twice daily topical application of delgocitinib cream for 8 weeks in adults, adoles... | bad-data | |
| Listed as ongoing, but also has a completion date and reported results | 2021-003543-16 | A 24 week, randomised, assessor blinded, active-controlled, parallel group, phase 3, 2 arm trial to compare the efficacy and safety of delgocitinib cream 20 mg/g twice-daily with alitretinoin capsules... | 2023-12-05 | bad-data |
| Other | 2021-005573-12 | A single (assessor) blinded, randomised, parallel-group, monotherapy trial to evaluate the pharmacokinetic and safety of tralokinumab in children (age 2 to <12 years) with moderate-to-severe atopic de... | not-yet-due | |
| Listed as ongoing, but also has a completion date | 2021-006340-27 | A phase 3 clinical trial to evaluate efficacy and safety of twice daily applications of delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adolescents 12-17 years... | 2024-12-17 | bad-data |